These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 310248)

  • 1. Immunological features of kala-azar.
    Rezai HR; Ardehali SM; Amirhakimi G; Kharazmi A
    Am J Trop Med Hyg; 1978 Nov; 27(6):1079-83. PubMed ID: 310248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological findings in kala-azar, Iran.
    Behforouz NC; Amirhakimi GH; Rezai HR; Saberi MS
    Trop Geogr Med; 1983 Mar; 35(1):27-32. PubMed ID: 6612770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the presence of circulating immune complexes in serum and C3b and C3d on red cells of kala-azar patients.
    Kharazmi A; Rezai HR; Fani M; Behforouz NC
    Trans R Soc Trop Med Hyg; 1982; 76(6):793-6. PubMed ID: 6761907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B lymphocyte population and immunoglobulins in Indian kala-azar in response to chemotherapy.
    Neogy AB; Nandy A; Dastidar BG; Chowdhury AB
    Acta Trop; 1986 Sep; 43(3):237-44. PubMed ID: 2877550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis.
    Haldar JP; Ghose S; Saha KC; Ghose AC
    Infect Immun; 1983 Nov; 42(2):702-7. PubMed ID: 6642649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological profiles in Indian post kala-azar dermal leishmaniasis.
    Haldar JP; Saha KC; Ghose AC
    Trans R Soc Trop Med Hyg; 1981; 75(4):514-7. PubMed ID: 7324125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunodiagnostic findings in patients with kala-azar].
    Mannweiler E; Lederer I; Feldmeier H
    Dtsch Med Wochenschr; 1988 Sep; 113(37):1428-32. PubMed ID: 3046895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of immunoglobins in kala-azar].
    Patanè R; Pavone L
    Pediatria (Napoli); 1969; 77(4):575-82. PubMed ID: 4188930
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic findings in juvenile Mediterranean kala-azar].
    Koletzko B; von Kries R; Wahn V
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):96-9. PubMed ID: 6328286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Seroimmunological profile of kala-azar in Tunisia].
    Ben Said M; Ben Rachid MS; Ayed K; Makni S; Farhat M
    Bull Soc Pathol Exot Filiales; 1984; 77(1):52-68. PubMed ID: 6373035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC).
    Gasim S; Elhassan AM; Kharazmi A; Khalil EA; Ismail A; Theander TG
    Clin Exp Immunol; 2000 Mar; 119(3):523-9. PubMed ID: 10691926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cellular immunological responses in mono- and polymorphic clinical forms of post-kala-azar dermal leishmaniasis in India.
    Kaushal H; Bras-Gonçalves R; Avishek K; Kumar Deep D; Petitdidier E; Lemesre JL; Papierok G; Kumar S; Ramesh V; Salotra P
    Clin Exp Immunol; 2016 Jul; 185(1):50-60. PubMed ID: 26948150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocyte changes in Mediterranean kala-azar.
    Musumeci S; Schilirò G; Li Volti S; Sciotto A
    Trans R Soc Trop Med Hyg; 1981; 75(2):304-5. PubMed ID: 7303141
    [No Abstract]   [Full Text] [Related]  

  • 14. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serological investigations on Indian kala-azar.
    Ghose AC; Haldar JP; Pal SC; Mishra BP; Mishra KK
    Clin Exp Immunol; 1980 May; 40(2):318-26. PubMed ID: 7438541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antileishmania antibodies and functional activity of complement components in patients with visceral leishmaniasis in Kenya.
    Koech DK; Lyerly WH; Iha DW
    East Afr Med J; 1982 Oct; 59(10):665-70. PubMed ID: 7185558
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential role for interleukin-10 in the immunosuppression associated with kala azar.
    Holaday BJ; Pompeu MM; Jeronimo S; Texeira MJ; Sousa Ade A; Vasconcelos AW; Pearson RD; Abrams JS; Locksley RM
    J Clin Invest; 1993 Dec; 92(6):2626-32. PubMed ID: 8254019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatitis herpetiformis: lymphocytes, immunoglobulins and complement factors in peripheral blood.
    Braathen LR; Førre O; Natvig JB
    Acta Derm Venereol; 1979; 59(1):39-44. PubMed ID: 84465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T and B lymphocytes, immunoglobulins and complement components in bronchial asthma.
    Pryjma J; Sciślicki A; Rusinek B; Pryjma K
    Allergol Immunopathol (Madr); 1978; 6(3):209-16. PubMed ID: 309715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.